摘要
抗菌素耐药性在世界范围内是一个日益严重的问题,已经达到了严重的程度。两种常见的被忽视的热带病是南美锥虫病和利什曼病。南美锥虫病是一种严重的健康问题,主要在拉丁美洲,每年造成约50000人死亡,数百万人受到感染。约有25-30%的感染克氏锥虫的患者发展为慢性病。另一方面,利什曼病是一种具有重要临床和流行病学多样性的复杂疾病。在88个国家流行,其中72个国家是发展中国家,估计有1200万人受感染,3.5亿在感染风险地区。在此基础上,研究可以用来对付这两种疾病的有机化合物是一个重要的研究目标。开发了一种非常简单,绿色且有效的方案,其中在微波照射下在含水介质中使用五水硝酸铋作为路易斯酸催化剂,由醛和邻苯二胺合成各种2-芳基取代的苯并咪唑。该协议的其他显着特点包括温和的条件,原子经济,容易提取,没有浪费。合成了9位具有2位和5位取代基的1H-苯并咪唑衍生物(1-9),并用光谱法对化合物的结构进行了阐明。筛选化合物以确定它们是否具有针对南美锥虫病和利什曼病的药理活性。化合物8比对照Nifurtimox对INC-5克氏锥虫菌株显示出更好的活性,而化合物3和9显示出有效的杀虫活性。描述了一种系统的绿色合成程序和9种1H-苯并咪唑的体外生物学评价。
关键词: 苯并咪唑,查加斯病,利什曼病,绿色化学,微波,硝酸铋五水合物。
Current Medicinal Chemistry
Title:A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis
Volume: 24 Issue: 41
关键词: 苯并咪唑,查加斯病,利什曼病,绿色化学,微波,硝酸铋五水合物。
摘要: Antimicrobial resistance is an ever-increasing problem throughout the world and has already reached severe proportions. Two very common neglected tropical diseases are Chagas' disease and leishmaniasis. Chagas' disease is a severe health problem, mainly in Latin America, causing approximately 50000 deaths a year and millions of people are infected. About 25-30% of the patients infected with Trypanosoma cruzi develop the chronic form of the disease. On the other hand, Leishmaniasis represents complex diseases with an important clinical and epidemiological diversity. It is endemic in 88 countries 72 of which are developing countries and it has been estimated that are 12 million people infected and 350 million are in areas with infection risk. On this basis, research on organic compounds that can be used against these two diseases is an important target. A very simple, green, and efficient protocol is developed in which bismuth nitrate pentahydrate is employed as a Lewis acid catalyst in aqueous media under microwave irradiation for the synthesis of various 2-aryl substituted benzimidazoles from aldehydes and o-phenylenediamine. Other salient features of this protocol include milder conditions, atom-economy, easy extraction, and no wastes. Nine 1H-benzimidazole derivatives (1-9) with substituents at positions 2 and 5 were synthesized and the structure of the compounds was elucidated by spectroscopic methods. The compounds were screened to identify whether they posses pharmacological activity against Chagas' disease and leishmaniasis. Compound 8 showed better activity than the control Nifurtimox against INC-5 Trypanosoma cruzi strain whereas compounds 3 and 9 have demonstrated potent leshmanicidal activity. A systematic green synthetic procedure and in vitro biological evaluation of nine 1H-benzimidazoles are described.
Export Options
About this article
Cite this article as:
A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis, Current Medicinal Chemistry 2017; 24 (41) . https://dx.doi.org/10.2174/0929867325666171201101807
DOI https://dx.doi.org/10.2174/0929867325666171201101807 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel S-Nitrosothiols Have Potential Therapeutic Uses for Cystic Fibrosis
Current Pharmaceutical Design Selective Activation of Intracellular Signalling Pathways in Dendritic Cells for Cancer Immunotherapy
Anti-Cancer Agents in Medicinal Chemistry Targeting Adhesion Molecules in Cardiovascular Disorders
Cardiovascular & Hematological Disorders-Drug Targets Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing- Remitting Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets New Biological Approaches in Asthma: DNA-Based Therapy
Current Medicinal Chemistry The Potential of Natural Products as Effective Treatments for Allergic Inflammation: Implications for Allergic Rhinitis
Current Topics in Medicinal Chemistry Immunomodulatory Therapy Associated to Anti-Parasite Drugs as a Way to Prevent Severe Forms of Malaria
Current Clinical Pharmacology Recent Approaches on Novel Topical Delivery Systems for Atopic Dermatitis Treatment
Recent Patents on Drug Delivery & Formulation Editorial from Guest Editor [Hot Topic:Vitamin D and Respiratory Health (Guest Editor: Adrian R. Martineau)]
Current Respiratory Medicine Reviews Transforming Growth Factor-Beta: A Potential New Agent for Pleurodesis
Drug Design Reviews - Online (Discontinued) Adverse Reactions to Iodinated Contrast Media Administered at the Time of Endoscopic Retrograde Cholangiopancreatography (ERCP)
Inflammation & Allergy - Drug Targets (Discontinued) Cyclosporin A: A Therapeutic Strategy in Allergic Diseases
Letters in Drug Design & Discovery Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Antisense Oligonucleotide Drug Design
Current Pharmaceutical Design Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets In Vitro Effects of Nickel on Healthy Non-Allergic Peripheral Blood Mononuclear Cells. The Role of Red Grape Polyphenols
Endocrine, Metabolic & Immune Disorders - Drug Targets S-Nitrosylation: Targets, Controls and Outcomes
Current Genomics Stem Cells in Stroke Repair: Current Success & Future Prospects
CNS & Neurological Disorders - Drug Targets Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]
Current Pharmaceutical Design Antioxidants and Mucolytics in COPD Management: When (if ever) and in Whom?
Current Drug Targets